Supraflex Cruz evidence presented at TCT 2025
In November 2025, EUKON shared an update from Sahajanand Medical…
LaaGuarder: first European clinical use announced by EUKON
In January 2026, EUKON announced the first clinical use in Europe of the LaaGuarder left atrial appendage closure system at Clinica Montevergine in Mercogliano, Italy.
The milestone reflects collaboration between the clinical team, EUKON and Shenqi Medical, with technical and operational support for the introduction of the technology.
EUKON thanked the clinicians involved for their expertise and procedural coordination, and Shenqi Medical for its support. The announcement highlights the role of close collaboration between healthcare professionals, manufacturers and local product specialists in bringing new structural heart technologies into clinical practice.
For product information and local support, contact EUKON.
Read the original EUKON announcement, published on 27 January 2026.
Latest News:
Supraflex Cruz NEVO now available to Italian cath labs
EUKON announced the availability of Supraflex Cruz NEVO to Italian…
AIR-STEMI: new evidence for physiology-guided revascularisation
The AIR-STEMI trial was presented by Associate Professor Simone Biscaglia…